history of glp 1 drugs The evolution weight loss drugs: from dangers to GLP-1 blockbusters | BioKnow posted on the topic GLP-1s: The world's first longevity
Description
S2CID 35102048
doi:10.2967/jnumed.106.038679 80
What don't we know
Semaglutides STEP-1 trial landed at 14.9 percent over 68 weeks, and tirzepatides SURMOUNT-1 hit 20.9 percent at its top dose over 72 weeks
Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain
Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats
